FDA Inspection 1229140 — Hospira, Inc.
The FDA completed an inspection of Hospira, Inc. on Mar 27, 2024 in Mcpherson, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Mar 27, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Mcpherson, KS (United States)